91Ó°ÊÓ

Understanding the life cycle of HIV-1 is essential to grasp how certain treatments work. HIV-1, a type of human immunodeficiency virus, first enters human immune cells.
Once inside, it releases its RNA into the cell. This viral RNA is then converted into DNA through a process called reverse transcription, thanks to the enzyme reverse transcriptase.
The newly formed viral DNA is integrated into the host’s own DNA in the cell nucleus. This integration is crucial because it allows the virus to hijack the host's cellular machinery to produce viral proteins. These viral proteins are necessary to build new viral particles.
Lastly, the new viral particles are assembled and exit the host cell in a process called budding. These steps are targets for various antiretroviral drugs.

The protease enzyme plays a vital role in the HIV-1 life cycle. Once the viral proteins are produced from the integrated viral DNA, they are initially in a long, immature form.
HIV-1 protease's job is to cut these long protein chains into smaller, functional units.
These functional units are essential for the viral particles to mature and become infectious. If these proteins aren’t cut correctly, the virus cannot assemble properly, which means it cannot infect new cells effectively.
This enzyme becomes a key target for HIV therapies aimed at stopping the virus in its tracks.

Protease inhibitors are a class of drugs designed to disrupt the HIV-1 life cycle by specifically targeting the protease enzyme. These drugs bind to the protease, blocking its ability to cleave viral proteins.
When the protease is inhibited, the newly produced viral particles remain in their immature form, unable to mature into an infectious state.
As a result, the virus loses its ability to replicate and spread to new cells. This significantly reduces the viral load in the patient's body, helping to manage the infection effectively.
In summary, by inhibiting the protease, these drugs effectively prevent the virus from continuing its life cycle and causing further damage.